Positive Phase IIa Data Reported For Novel Oxygen Therapeutic Agent MP4OX In Trauma Patients
Links shared publicly online about this topic.
- 905total visits
Positive Phase IIa Data Reported For Novel Oxygen Therapeutic Agent MP4OX In Trauma Patients
Sangart, Inc., has announced positive results from its Phase IIa proof-of-concept study of MP4OX (oxygenated pegylated hemoglobin) in severely injured trauma patients with hemorrhagic shock causin
View full resource at medicalnewstoday.com
Most Recently Shared on September 1, 2010 at 7:00 pm By:
Positive Phase IIa Data Reported For Novel Oxygen Therapeutic Agent MP4OX In Trauma Patients http://mnt.to/3J7N #vascular
Also Shared By:
Advertisement
medical_tweets
@medical_tweets
Positive Phase IIa Data Reported For Novel Oxygen Therapeutic Agent MP4OX In Trauma Patients Sangart, Inc., has announc.. http://dld.bz/uc3t
1 year ago...